The Evolution Of Obama’s Drug Addiction And Mental Health Policy

Drug Policy Innovation In Disease Diagnosis

As part of the ACA rollout, President Obama’s 21st-century drug policy strategy for America was released in 2012. It is designed to take drug counseling and addiction treatment health care measures further through progressive public health and public safety strategies.

The scope of the new policies is quite broad: they cover addiction diagnosis, mental health counseling, all forms of drug testing, addiction recovery, dual-diagnoses and much more.…

Continue Reading

The Importance Of Creating Professional, Responsible Public Policies In Healthcare

Health Care  Policies

As patients, we all demand the same level of care and treatment as the next person. All patients should be given the best available care that complies with responsible safety guidelines and best practice. There is a lot of pressure to maintain these regulations, with a constant need to meet requirements within financial means.

It is far too easy for practices to become outdated if these responsibilities are neglected. It is, therefore, vital that practices and healthcare providers work on careful, professional healthcare policies for staff. There …

Continue Reading

The Human Microbiome A New Frontier In Drug Discovery

Life Science Research In Drug Discovery

The notion of The Human Microbiome is one that has expanded significantly in recent years. The concept is still pretty new to the average American, but researchers and scientists are making significant progress. These advances in life science research are largely down to two factors. First, there is the fact that scientists are now getting to grips with the actual influence of the gut microbiome on health. Second, significant funding was newly declared that gives researchers the chance to delve deeper.…

Continue Reading

Novartis Continue To Battle Roche To Create The Number One Lung Cancer Drug

Novartis Vs Roche

The Disease Diagnosis Innovation is becoming a battle to produce the leading drug for lung cancer is heating up.On one side is Zykadia from Novartis. On the other is a product called Alecensa from Roche, their current rival. Both healthcare companies already have the approval they need to be used as a second-line treatment option when Xalkori is not an option. Now the battle is on to become the number one option.…

Continue Reading

The Dangers Of Straying From Standardized Guidelines Within Public Healthcare

Health Care Policies Standardized Guidelines

Discrepancies in the creation of healthcare policies and their interpretation can lead to different levels of care in one organization. This increases that organization’s risk exposure. There are potential outcomes here that healthcare providers need to avoid. The Joint Commission set the following leadership accreditation standard as an essential requirement.…

Continue Reading

Advancements In STD Testing And Implications On Rural America

Life Science Research Advancements In STD Testing

Time-consuming processes, high expense and lack of access to testing labs used to be the biggest problems with STD testing.  It could take days for elaborate bioassays to determine results. This was important to get the best, most accurate result.

Today, however, there has been an explosion of new technologies and new STD testing methods that make it far cheaper and easier for the 448 million new cases of curable STIs each year to be diagnosed early and treated.

According to STDTestOptions.info

Continue Reading

The New NIH Final Rule Is Getting Tough On Non-Compliant Researchers

Health Care Policies: NIH Final Rule

New requirements on final clinical trial registration and reporting were released on September 16th. These new rulings could have a massive impact on the fate of trials. In some cases, the NIH may freeze grant funding if they fail to make the grade. The NIH is currently the largest public funder for these clinical trials, with an annual spend of $3 billion. This should appear as no shock to the many companies and research institutions involved. The draft outlines have been publicly available since …

Continue Reading

Congress Promises $2 Billion In Extra Spending On US Life Sciences

Life Science Research In America

The American health care industry relies on the health policies of the US government to survive. The recent good news from Congress suggests that 2017 could be another great year. The US Senate has just declared funding for the National Institutes of Health. This means they are declaring it to be a national priority two years in a row.…

Continue Reading

New Innovations Are Changing The Way We Treat Type 2 Diabetes

Disease Diagnose Innovations  In Treating Type 2 Diabetes

Diabetes has become prevalent in modern society due to declining standards of diets and other environmental factors. Change in the diagnosis of type 2 diabetes has led to some exciting discoveries in recent years. We now know more about the disease and the physiological and chemical changes that occur within the body. This has lead to some interesting new drugs and medications for treating type 2 diabetes.…

Continue Reading

The Impact of Brexit On the Life Sciences Industry

Health Policies For The Life Sciences Industry

The historic UK referendum on the nation’s relationship with the EU led to a surprising result. The majority of the people wanted to leave.

This severing of ties – now more commonly referred to as Brexit – has cast some doubts over the ongoing UK/EU relationship concerning healthcare and the life sciences industry.

There is plenty of debate over the way in which Brexit will have an impact on this industry. At the time, there is no clear answer as there are so …

Continue Reading